CD8A and cancer: HDAC3-deficient CD8+ cells enhance granzyme B expression and anti-viral effects in a chronic viral infection model [89], suggesting that HDAC3-targeted inhibition is a potent therapeutic treatment against cancers via enhancement of cytotoxic molecule actions against cancer.